Clinical Trials Browser

Completed × Interventional × telisotuzumab vedotin × Clear all

NCT03574753 2021-10-18

Lung-MAP S1400K: c-MET Positive

Phase 2 Completed

28 enrolled 18 charts

Recurrent Squamous Cell Lung Carcinoma

NCT03311477 2019-03-14

A Study to Evaluate the Safety and Pharmacokinetics ABBV-399 in Japanese Participants With Solid Tumors

Phase 1 Completed

Neoplasms

NCT01472016 2017-11-21

Study of ABT-700 in Subjects With Advanced Solid Tumors

Phase 1 Completed

Neoplasms